Briefing Industry news Industry briefing NEWS Emergent acquires global rights for smallpox antiviral from Chimerix Emergent BioSolutions has acquired exclusive global rights for oral smallpox antiviral, Tembexa (brincidofovir), from Chimerix news Myovant rejects Sumitovant and Sumitomo’s $2.5bn acquisition offer Myovant Sciences has rejected an acquisition offer worth $2.5bn from Sumitovant Biopharma and its wholly-owned subsidiary Sumitomo Pharma Briefing FDA grants approval for Amylyx’s Relyvrio to treat ALS The US FDA has granted approval for Amylyx Pharmaceuticals’ Relyvrio to treat adult patients with amyotrophic lateral sclerosis (ALS) Industry news Industry briefing 02/23/2024 23:28:26
Briefing
FDA grants approval for Amylyx’s Relyvrio to treat ALS
The US FDA has granted approval for Amylyx Pharmaceuticals’ Relyvrio to treat adult patients with amyotrophic lateral sclerosis (ALS)